| Insider | Role | Holdings | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| Carl Aaron Hess | Chief Executive Officer, Director | 117,548 | $510,160 | $3,091,316 | -$2,581,156 |
| Julie Jarecke Gebauer | Pres.-Health, Wealth & Career | 78,034 | — | $1,683,648 | -$1,683,648 |
| Lucy Clarke | President of Risk & Broking | 22,759 | $1,496,269 | — | $1,496,269 |
| Matthew Furman | General Counsel | 35,561 | — | $912,009 | -$912,009 |
| Andrew Jay Krasner | Chief Financial Officer | 4,475 | — | $505,200 | -$505,200 |
| Alexis Faber | Chief Operating Officer | 10,752 | — | $331,506 | -$331,506 |
| Michael P. Hammond | Director | 3,089 | $67,205 | — | $67,205 |
| Date | Insider | Side | Shares | Price | Value | Holdings After | % of Position |
|---|---|---|---|---|---|---|---|
| 2026-08-10 | Alexis Faber | SELL | 730 | $342.70 | $250,172 | 10,752 | 6% |
| 2026-05-06 | Lucy Clarke | BUY | 1,896 | $263.37 | $499,340 | 22,717 | 9% |
| 2026-05-04 | Carl Aaron Hess | BUY | 2,000 | $255.08 | $510,160 | 117,425 | 2% |
| 2026-03-03 | Matthew Furman | SELL | 3,000 | $304.00 | $912,009 | 38,185 | 7% |
| 2026-02-13 | Lucy Clarke | BUY | 3,500 | $284.84 | $996,929 | 19,250 | 22% |
| 2026-02-12 | Michael P. Hammond | BUY | 241 | $278.86 | $67,205 | 2,505 | 11% |
| 2025-06-03 | Andrew Jay Krasner | SELL | 1,600 | $315.75 | $505,200 | 11,982 | 12% |
| 2025-05-08 | Carl Aaron Hess | SELL | 146 | $306.85 | $44,800 | 95,838 | 0% |
| 2025-05-08 | Carl Aaron Hess | SELL | 192 | $307.91 | $59,118 | 95,646 | 0% |
| 2025-05-08 | Carl Aaron Hess | SELL | 6,062 | $308.78 | $1,871,827 | 89,584 | 6% |
| 2025-05-08 | Carl Aaron Hess | SELL | 2,891 | $309.67 | $895,256 | 86,693 | 3% |
| 2025-05-08 | Carl Aaron Hess | SELL | 709 | $310.74 | $220,314 | 85,984 | 1% |
| 2025-05-08 | Alexis Faber | SELL | 265 | $306.92 | $81,334 | 7,981 | 3% |
| 2025-03-03 | Julie Jarecke Gebauer | SELL | 1,616 | $338.74 | $547,405 | 72,793 | 2% |
| 2025-02-28 | Julie Jarecke Gebauer | SELL | 3,384 | $335.77 | $1,136,243 | 74,417 | 4% |